| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | DCAF1 TNIK PLK2 MAK MAP4K3 PDK2 CDK19 MAP3K4 NEK3 MAST4 BUB1 TOP1 | 1.03e-05 | 446 | 115 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | kinase activity | DCAF1 TNIK PLK2 MAK MAP4K3 PDK2 CDK19 DGKB MAP3K4 CKB NEK3 MAST4 BUB1 MERTK TOP1 | 3.28e-05 | 764 | 115 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | protein kinase activity | DCAF1 TNIK PLK2 MAK MAP4K3 PDK2 CDK19 MAP3K4 NEK3 MAST4 BUB1 MERTK TOP1 | 4.23e-05 | 600 | 115 | 13 | GO:0004672 |
| GeneOntologyMolecularFunction | protein serine kinase activity | 4.78e-05 | 363 | 115 | 10 | GO:0106310 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | DCAF1 TNIK PLK2 MAK MAP4K3 PDK2 CDK19 DGKB MAP3K4 NEK3 MAST4 BUB1 MERTK TOP1 | 5.77e-05 | 709 | 115 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | histone H2A kinase activity | 9.83e-05 | 3 | 115 | 2 | GO:0140995 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | DCAF1 TNIK PLK2 MAK MAP4K3 PDK2 CDK19 DGKB MAP3K4 CKB NEK3 MAST4 BUB1 MERTK TOP1 | 3.17e-04 | 938 | 115 | 15 | GO:0016772 |
| GeneOntologyBiologicalProcess | neuron projection development | VAPA TNIK CACNA1A EVL PLK2 ABI1 NEDD4L ANK3 BLOC1S4 LZTS3 GATA3 MAPK8IP3 NEK3 IFRD1 MYPN SLIT1 VASH2 NUMB VPS13B USP33 | 3.44e-05 | 1285 | 117 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TNIK CACNA1A EVL ABI1 NEDD4L ANK3 LZTS3 GATA3 MAPK8IP3 NEK3 IFRD1 MYPN SLIT1 NUMB USP33 | 4.85e-05 | 802 | 117 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TNIK CACNA1A EVL ABI1 NEDD4L ANK3 LZTS3 GATA3 MAPK8IP3 NEK3 IFRD1 MYPN SLIT1 NUMB USP33 | 6.15e-05 | 819 | 117 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TNIK CACNA1A EVL ABI1 NEDD4L ANK3 LZTS3 GATA3 MAPK8IP3 NEK3 IFRD1 MYPN SLIT1 NUMB USP33 | 6.77e-05 | 826 | 117 | 15 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TNIK CACNA1A EVL ABI1 NEDD4L ANK3 LZTS3 GATA3 MAPK8IP3 IFRD1 MYPN SLIT1 NUMB USP33 | 8.76e-05 | 748 | 117 | 14 | GO:0048667 |
| Pubmed | DCAF1 TNIK FNBP1 NEDD4L CDK19 VPS8 DGKB URB2 MAP3K4 SLIT1 VPS13B USP33 | 2.29e-08 | 407 | 122 | 12 | 12693553 | |
| Pubmed | CACNB2 ABI1 ANK3 CUBN ADAM8 PRPF18 SLF2 MYPN SLIT1 MKI67 HACD1 CFAP46 | 2.83e-08 | 415 | 122 | 12 | 16385451 | |
| Pubmed | CACNA1A EVL CACNB2 ABI1 NEDD4L ANK3 LZTS3 MAP4K3 DGKB GEMIN5 PSMD3 ACTN3 PLEKHA6 ARCN1 MAPK8IP3 CKB C12orf50 BSN ATP2B3 TOP1 | 1.31e-07 | 1431 | 122 | 20 | 37142655 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FNBP1 EVL CACNB2 TRPC4AP NEDD4L ANK3 MID2 KIZ CDK19 ASH1L WDR27 ZSWIM1 MAPK8IP3 ZNF462 IFRD1 ZNF638 NUMB VGLL4 VPS13B | 1.10e-06 | 1489 | 122 | 19 | 28611215 |
| Pubmed | The leucine zipper putative tumor suppressor 2 protein LZTS2 regulates kidney development. | 6.81e-06 | 11 | 122 | 3 | 21949185 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 9.70e-06 | 38 | 122 | 4 | 30786075 | |
| Pubmed | 1.17e-05 | 13 | 122 | 3 | 15931389 | ||
| Pubmed | Gata3 directly regulates early inner ear expression of Fgf10. | 1.22e-05 | 2 | 122 | 2 | 23220102 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24688054 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21092861 | ||
| Pubmed | The T cell receptor from an influenza-A specific murine CTL clone. | 1.22e-05 | 2 | 122 | 2 | 2784852 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19659929 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19946260 | ||
| Pubmed | Gata-3 and KI-67 expression in correlation with molecular subtypes of breast cancer. | 1.22e-05 | 2 | 122 | 2 | 34057115 | |
| Pubmed | A conserved sequence in the T-cell receptor beta-chain promoter region. | 1.22e-05 | 2 | 122 | 2 | 3259318 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 32988889 | ||
| Pubmed | Immunohistochemical study of DNA topoisomerase I, p53, and Ki-67 in uterine carcinosarcomas. | 3.65e-05 | 3 | 122 | 2 | 17490723 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 1532150 | ||
| Pubmed | Genomic convergence to identify candidate genes for Alzheimer disease on chromosome 10. | 3.65e-05 | 3 | 122 | 2 | 19241460 | |
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 18313230 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 32472715 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 22879586 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 3490968 | ||
| Pubmed | 3.65e-05 | 3 | 122 | 2 | 23792956 | ||
| Pubmed | BCL6 controls neurogenesis through Sirt1-dependent epigenetic repression of selective Notch targets. | 3.92e-05 | 19 | 122 | 3 | 23160044 | |
| Pubmed | VAPA MED8 GATA3 MAML1 PSMD3 RFX7 CKB ZNF462 KLF10 MDC1 MKI67 GNL2 ZBTB10 ZNF638 VGLL4 TOP1 | 4.13e-05 | 1429 | 122 | 16 | 35140242 | |
| Pubmed | 4.17e-05 | 263 | 122 | 7 | 34702444 | ||
| Pubmed | 4.67e-05 | 591 | 122 | 10 | 15231748 | ||
| Pubmed | VAPA TNIK CACNA1A EVL ABI1 NEDD4L ANK3 LZTS3 PDK2 PSMD3 ARCN1 MAPK8IP3 CRYBG3 BSN | 4.82e-05 | 1139 | 122 | 14 | 36417873 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIAA0930 PLK2 ABI1 NEDD4L RFX7 RADIL IFRD1 MAST4 SLF2 NUMB FAM53B CRYBG3 | 5.29e-05 | 861 | 122 | 12 | 36931259 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | VAPA DCAF1 KIAA0930 NEDD4L PSMD3 ARCN1 CKB MRM3 SCML2 GNL2 JOSD1 ASCC3 USP33 | 5.46e-05 | 1005 | 122 | 13 | 19615732 |
| Pubmed | VAPA TNIK PIGK MAML1 PRPF18 SCML2 MDC1 GNL2 ZNF638 PRR14L USP33 | 5.71e-05 | 733 | 122 | 11 | 34672954 | |
| Pubmed | 6.18e-05 | 22 | 122 | 3 | 27335464 | ||
| Pubmed | 6.18e-05 | 22 | 122 | 3 | 27824289 | ||
| Pubmed | 7.29e-05 | 4 | 122 | 2 | 24821222 | ||
| Pubmed | 7.29e-05 | 4 | 122 | 2 | 34634443 | ||
| Pubmed | 7.29e-05 | 4 | 122 | 2 | 26363003 | ||
| Pubmed | Murine T-cell receptor mutants with deletions of beta-chain variable region genes. | 7.29e-05 | 4 | 122 | 2 | 3456168 | |
| Pubmed | 7.29e-05 | 4 | 122 | 2 | 20484821 | ||
| Pubmed | Tandem linkage and unusual RNA splicing of the T-cell receptor beta-chain variable-region genes. | 7.29e-05 | 4 | 122 | 2 | 3470773 | |
| Pubmed | Nedd4-2-dependent ubiquitylation and regulation of the cardiac potassium channel hERG1. | 7.29e-05 | 4 | 122 | 2 | 21463633 | |
| Pubmed | Germline organization of the murine T cell receptor beta-chain genes. | 1.21e-04 | 5 | 122 | 2 | 2821625 | |
| Pubmed | Harderian Gland Development and Degeneration in the Fgf10-Deficient Heterozygous Mouse. | 1.21e-04 | 5 | 122 | 2 | 38921483 | |
| Pubmed | 1.21e-04 | 5 | 122 | 2 | 16787652 | ||
| Pubmed | 1.21e-04 | 5 | 122 | 2 | 15280212 | ||
| Pubmed | 1.23e-04 | 72 | 122 | 4 | 31248990 | ||
| Pubmed | 1.25e-04 | 421 | 122 | 8 | 36976175 | ||
| Pubmed | TopBP1 controls BLM protein level to maintain genome stability. | 1.44e-04 | 29 | 122 | 3 | 24239288 | |
| Pubmed | 1.81e-04 | 6 | 122 | 2 | 31619968 | ||
| Pubmed | Genome-wide association study of bipolar I disorder in the Han Chinese population. | 1.81e-04 | 6 | 122 | 2 | 20386566 | |
| Pubmed | 1.81e-04 | 6 | 122 | 2 | 23589291 | ||
| Pubmed | RING finger protein RNF207, a novel regulator of cardiac excitation. | 1.81e-04 | 6 | 122 | 2 | 25281747 | |
| Pubmed | A β(IV)-spectrin/CaMKII signaling complex is essential for membrane excitability in mice. | 1.81e-04 | 6 | 122 | 2 | 20877009 | |
| Pubmed | 1.81e-04 | 6 | 122 | 2 | 10328888 | ||
| Pubmed | Lhx9 gene expression during early limb development in mice requires the FGF signalling pathway. | 1.81e-04 | 6 | 122 | 2 | 26220830 | |
| Pubmed | 1.81e-04 | 6 | 122 | 2 | 14767162 | ||
| Pubmed | 1.88e-04 | 335 | 122 | 7 | 15741177 | ||
| Pubmed | 1.94e-04 | 32 | 122 | 3 | 33669244 | ||
| Pubmed | 1.94e-04 | 32 | 122 | 3 | 27806288 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.09e-04 | 341 | 122 | 7 | 32971831 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | VAPA DCAF1 KIF18A KIAA0930 TRPC4AP MAK ABI1 ANK3 MAML1 BUB1 OSBPL1A ZNF638 NUMB FAM53B | 2.27e-04 | 1321 | 122 | 14 | 27173435 |
| Pubmed | 2.33e-04 | 347 | 122 | 7 | 17114649 | ||
| Pubmed | Hierarchical CRMP2 posttranslational modifications control NaV1.7 function. | 2.53e-04 | 7 | 122 | 2 | 27940916 | |
| Pubmed | A Novel Role for GATA3 in Mesangial Cells in Glomerular Development and Injury. | 2.53e-04 | 7 | 122 | 2 | 31405951 | |
| Pubmed | The Histone Methyltransferase Ash1l is Required for Epidermal Homeostasis in Mice. | 2.53e-04 | 7 | 122 | 2 | 28374742 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 3.11e-04 | 364 | 122 | 7 | 24778252 | |
| Pubmed | VAPA TNIK NEDD4L PIGK ACTN3 ARCN1 CKB MRM3 MKI67 GNL2 NUMB ASCC3 CDKN2AIPNL TOP1 | 3.31e-04 | 1371 | 122 | 14 | 36244648 | |
| Pubmed | 3.37e-04 | 8 | 122 | 2 | 12775724 | ||
| Pubmed | 3.37e-04 | 8 | 122 | 2 | 18586225 | ||
| Pubmed | miR-205 is a critical regulator of lacrimal gland development. | 3.37e-04 | 8 | 122 | 2 | 28511845 | |
| Pubmed | Identification of MOSPD2, a novel scaffold for endoplasmic reticulum membrane contact sites. | 3.37e-04 | 8 | 122 | 2 | 29858488 | |
| Pubmed | 3.37e-04 | 8 | 122 | 2 | 11309420 | ||
| Pubmed | 3.37e-04 | 8 | 122 | 2 | 25344367 | ||
| Pubmed | Development of the mammalian urethra is controlled by Fgfr2-IIIb. | 3.37e-04 | 8 | 122 | 2 | 15843416 | |
| Pubmed | Dlk1 is a negative regulator of emerging hematopoietic stem and progenitor cells. | 3.37e-04 | 8 | 122 | 2 | 22801971 | |
| Pubmed | 4.07e-04 | 41 | 122 | 3 | 8590280 | ||
| Pubmed | 4.07e-04 | 41 | 122 | 3 | 30377232 | ||
| Pubmed | 4.13e-04 | 503 | 122 | 8 | 16964243 | ||
| Pubmed | 4.32e-04 | 638 | 122 | 9 | 31182584 | ||
| Pubmed | CTCF deficiency causes expansion of the sensory domain in the mouse cochlea. | 4.32e-04 | 9 | 122 | 2 | 30929920 | |
| Pubmed | Differential transcriptional regulation of individual TCR V beta segments before gene rearrangement. | 4.32e-04 | 9 | 122 | 2 | 11160223 | |
| Pubmed | Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb. | 4.32e-04 | 9 | 122 | 2 | 11489975 | |
| Pubmed | Prox1 regulates Olig2 expression to modulate binary fate decisions in spinal cord neurons. | 4.32e-04 | 9 | 122 | 2 | 25411508 | |
| Pubmed | The E3 ubiquitin ligase Cul4b promotes CD4+ T cell expansion by aiding the repair of damaged DNA. | 4.32e-04 | 9 | 122 | 2 | 33524014 | |
| Pubmed | Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. | 4.32e-04 | 9 | 122 | 2 | 19744961 | |
| Pubmed | 4.32e-04 | 9 | 122 | 2 | 12874121 | ||
| Pubmed | FNBP1 CACNB2 ANK3 MAP4K3 ASH1L GEMIN5 CUBN SCML2 MYPN ZBTB10 ZNF638 VPS13B | 4.43e-04 | 1084 | 122 | 12 | 11544199 | |
| Pubmed | 4.53e-04 | 101 | 122 | 4 | 9872452 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK GEMIN5 ARCN1 CKB SCML2 MKI67 GNL2 ZNF638 NUMB PRR14L TOP1 | 4.63e-04 | 934 | 122 | 11 | 33916271 |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 4.70e-04 | 102 | 122 | 4 | 15778465 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.06e-04 | 283 | 122 | 6 | 30585729 | |
| Pubmed | 5.10e-04 | 653 | 122 | 9 | 22586326 | ||
| Pubmed | 5.24e-04 | 105 | 122 | 4 | 9628581 | ||
| Pubmed | 5.25e-04 | 285 | 122 | 6 | 32838362 | ||
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 5.39e-04 | 10 | 122 | 2 | 22159418 | |
| Pubmed | 5.39e-04 | 10 | 122 | 2 | 22855790 | ||
| Pubmed | 5.39e-04 | 10 | 122 | 2 | 15525534 | ||
| Pubmed | NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation. | 5.39e-04 | 10 | 122 | 2 | 33058421 | |
| Pubmed | 5.39e-04 | 10 | 122 | 2 | 20702712 | ||
| Pubmed | 5.85e-04 | 191 | 122 | 5 | 31177093 | ||
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP | DCAF1 ACP5 MRM3 IFRD1 KLF10 BUB1 ZNF638 FGF10 MERTK CDKN2AIPNL TOP1 | 2.18e-09 | 200 | 120 | 11 | M9633 |
| Coexpression | TSUTSUMI_FBXW8_TARGETS | 7.70e-06 | 9 | 120 | 3 | MM888 | |
| Coexpression | TSUTSUMI_FBXW8_TARGETS | 7.70e-06 | 9 | 120 | 3 | M2187 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-06 | 130 | 121 | 6 | 0f9d3e6297f48ae14d24ac997d8d3a94f337d4d4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.52e-06 | 130 | 121 | 6 | fc68a648161dd314d9ee6612fd039cb12171b8c6 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.36e-06 | 156 | 121 | 6 | 17c38d3b03fc38cb125cf0d165b2fd694cd88edd | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.00e-06 | 177 | 121 | 6 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-06 | 180 | 121 | 6 | cf6e9f757afeb342c5023f6e6152a1b4d0d164b4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-05 | 185 | 121 | 6 | e34473eea3a58c041183a4f52137366cd9489495 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-05 | 187 | 121 | 6 | b426a67b5669019115b58295ce7d304beeb75825 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T-T_NK-CD4_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.35e-05 | 190 | 121 | 6 | 8fdf35c2ad1d325c00c00e4fcf2506341ff14537 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-05 | 190 | 121 | 6 | 600b9674197f743dea1d19d3df0fc993b6e6aa25 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 191 | 121 | 6 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 191 | 121 | 6 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.39e-05 | 191 | 121 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.39e-05 | 191 | 121 | 6 | 3839bf57419d3ec3d4464277bb33301d2b7d701f | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.39e-05 | 191 | 121 | 6 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.43e-05 | 192 | 121 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.47e-05 | 193 | 121 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.47e-05 | 193 | 121 | 6 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | T_cells-Central_memory_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.47e-05 | 193 | 121 | 6 | 725326d7e3604736b607c19f4069c81cb4f2d20c | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.47e-05 | 193 | 121 | 6 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 194 | 121 | 6 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.51e-05 | 194 | 121 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.56e-05 | 195 | 121 | 6 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.56e-05 | 195 | 121 | 6 | f1f48e2e57b2282572959b152aad4bee05143f03 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.56e-05 | 195 | 121 | 6 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.56e-05 | 195 | 121 | 6 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-05 | 196 | 121 | 6 | efeb272bc9e37e60d15d056b7574991c5c7501bc | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.61e-05 | 196 | 121 | 6 | e08f90f7a923c2846cac859519b8dc7c0ac7cd03 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 197 | 121 | 6 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | 2b724d2a36843801984d46a969d33149b76c9771 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-05 | 198 | 121 | 6 | fcf53d6ac2e442400fa0c07c6de72e00a9143ba2 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.80e-05 | 200 | 121 | 6 | b7ab3f644e6002635771dccaa192a111b4e0ed5b | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.80e-05 | 200 | 121 | 6 | 2e01a35caeff5967a8b873c5122500d068dcf54c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.90e-05 | 139 | 121 | 5 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.45e-05 | 72 | 121 | 4 | 7877184d5c9dd6d96476d71e7504e58c0b4d0f26 | |
| ToppCell | severe_influenza-CD4+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 7.18e-05 | 158 | 121 | 5 | ff3fa4bd06e01363429aec4bb587b95819bf0fc9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.62e-05 | 160 | 121 | 5 | 8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 160 | 121 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 160 | 121 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.31e-05 | 163 | 121 | 5 | 56b8668dbf06faa6866ec71f29b92907b73f074d | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-NK_CD56bright|Multiple_Sclerosis / Disease, Lineage and Cell Type | 8.31e-05 | 163 | 121 | 5 | 82c4b25f05bd404fdee9aa90f23efd6dffc04e7b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.06e-05 | 166 | 121 | 5 | ceb0a48c0d853448fd45ac31dde046df9a178571 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.32e-05 | 167 | 121 | 5 | c2a0fdb35ec48b956be0686534b29164db6638ab | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 167 | 121 | 5 | 528493896aebe7d03d4b6ad2341b12927859e2e4 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 167 | 121 | 5 | a82e85caf79395baa48380786d9df32a86dfd1ce | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.86e-05 | 169 | 121 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Control-Myeloid-Mast|Control / Disease state, Lineage and Cell class | 1.01e-04 | 170 | 121 | 5 | 9a14deb7f7cd4a49c217eba4023f7bf1dec6c902 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 170 | 121 | 5 | 059f7ae615342ea19f43b0a405cd7272251a78a9 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.04e-04 | 171 | 121 | 5 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 1.04e-04 | 171 | 121 | 5 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.10e-04 | 173 | 121 | 5 | 7e3897868dd3f6e4974f593c60649a543ffc8693 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 174 | 121 | 5 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 174 | 121 | 5 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | Control-Lymphoid-Tregs|Lymphoid / Condition, Lineage and Cell class | 1.13e-04 | 174 | 121 | 5 | 522a6d5d9809271c63b85f62ac6ec52a6e3c355e | |
| ToppCell | moderate-Myeloid-Mast_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.16e-04 | 175 | 121 | 5 | bbd2971bc6d69e507f90a637834d0936c205c590 | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.19e-04 | 176 | 121 | 5 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 177 | 121 | 5 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 177 | 121 | 5 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-NK_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 177 | 121 | 5 | fcdd71e2a727ae24b726a39216ea02c06df1f593 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 177 | 121 | 5 | 16197068260fc062bf8b730a51a199887ea580b9 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 1.32e-04 | 180 | 121 | 5 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.32e-04 | 180 | 121 | 5 | f3d35b2ea78afef37a84232adf5e6e26712b618d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.32e-04 | 180 | 121 | 5 | d9dae9db8e17f6990032ee6cfa8393fae4768ca5 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.36e-04 | 181 | 121 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 182 | 121 | 5 | feda21c92d30848de70c8b404eaabbca3f5e894d | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 1.39e-04 | 182 | 121 | 5 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|CF / Disease state, Lineage and Cell class | 1.39e-04 | 182 | 121 | 5 | a8dfc59a3974e3433f434676b7c2749d0fcfc8b2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.47e-04 | 184 | 121 | 5 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.47e-04 | 184 | 121 | 5 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 1.47e-04 | 184 | 121 | 5 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.47e-04 | 184 | 121 | 5 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.47e-04 | 184 | 121 | 5 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 1.47e-04 | 184 | 121 | 5 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 184 | 121 | 5 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | control-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.47e-04 | 184 | 121 | 5 | fad517d047e8eaeaa5bd4f311d770880568dd13c | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 1.47e-04 | 184 | 121 | 5 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-04 | 186 | 121 | 5 | 86d145f965c311189e7996390eef491642417c5c | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 1.54e-04 | 186 | 121 | 5 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 186 | 121 | 5 | c793a3d5709ad504c12fc3b2337746d90236d3ca | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 186 | 121 | 5 | 35f32fc2761435356c8f54b5bb2f026b8c070efe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 186 | 121 | 5 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-04 | 187 | 121 | 5 | fae08f34dc4b15352bd4d10bc6c924fe119b5d5e | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-04 | 187 | 121 | 5 | e6b140b9fb582abf07aa6ea9bc437de3ba0d6de1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-04 | 187 | 121 | 5 | e1d6c1194476cf26969e405b0951796fed519f44 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.58e-04 | 187 | 121 | 5 | 9fdfca5b70f585843ef9d810154674a8e561e765 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.58e-04 | 187 | 121 | 5 | a525753a8a908ee1ef0b8f06e68855e4af27bf86 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.58e-04 | 187 | 121 | 5 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 188 | 121 | 5 | 1a3f95b4fd7611c634666761ddf21f1e58e56af8 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-04 | 188 | 121 | 5 | 9db3d3010cb8a1f3ee1cdccaf3cbaac3cf983fc5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.62e-04 | 188 | 121 | 5 | 72be6fe654f3a5f654d3b9680145bce7ae9b721d | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-Treg|COVID-19_Mild / Disease group, lineage and cell class | 1.62e-04 | 188 | 121 | 5 | 42553fdc127e5f613ffd5067620a768a40f1a8a1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 189 | 121 | 5 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 189 | 121 | 5 | 8130102c41b2978a8b83f765ce383f836a464795 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 189 | 121 | 5 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD4_TCM|ICU-SEP / Disease, Lineage and Cell Type | 1.66e-04 | 189 | 121 | 5 | 9ed1cf4bb456780c1d1070de687bcabafd6287a3 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.66e-04 | 189 | 121 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.70e-04 | 190 | 121 | 5 | 55df73c8b696967a925b1772631f6900eff0fa30 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.70e-04 | 190 | 121 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; PC3; HT_HG-U133A | 9.77e-07 | 199 | 118 | 9 | 7267_DN | |
| Disease | arachidonic acid measurement | 1.28e-04 | 25 | 116 | 3 | EFO_0006808 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 4.22e-04 | 8 | 116 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | dentate gyrus volume measurement | 4.88e-04 | 39 | 116 | 3 | EFO_0010083 | |
| Disease | hippocampal CA4 volume | 5.66e-04 | 41 | 116 | 3 | EFO_0009396 | |
| Disease | grey matter volume measurement | 6.97e-04 | 44 | 116 | 3 | EFO_0005420 | |
| Disease | Shortened QT interval | 8.23e-04 | 11 | 116 | 2 | C0151879 | |
| Disease | C-reactive protein measurement | CACNB2 ANK3 IL37 MAPK8IP3 RADIL KLF10 SPATA16 JOSD1 NUMB FAM227A MERTK BSN TOP1 | 9.28e-04 | 1206 | 116 | 13 | EFO_0004458 |
| Disease | Congenital myopathy (disorder) | 9.86e-04 | 12 | 116 | 2 | C0270960 | |
| Disease | N-acetyl-isoputreanine measurement | 1.16e-03 | 13 | 116 | 2 | EFO_0800107 | |
| Disease | T wave morphology measurement | 1.35e-03 | 14 | 116 | 2 | EFO_0008398 | |
| Disease | asthma, body mass index | 1.35e-03 | 14 | 116 | 2 | EFO_0004340, MONDO_0004979 | |
| Disease | Hypertrophic Cardiomyopathy | 1.48e-03 | 57 | 116 | 3 | C0007194 | |
| Disease | Tremor, Rubral | 1.77e-03 | 16 | 116 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.77e-03 | 16 | 116 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 1.77e-03 | 16 | 116 | 2 | C0278161 | |
| Disease | Abnormal coordination | 1.77e-03 | 16 | 116 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 1.77e-03 | 16 | 116 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 1.77e-03 | 16 | 116 | 2 | C0240991 | |
| Disease | Congenital Fiber Type Disproportion | 2.25e-03 | 18 | 116 | 2 | C0546264 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 2.51e-03 | 19 | 116 | 2 | EFO_0000220, GO_0097327 | |
| Disease | JT interval | 3.03e-03 | 248 | 116 | 5 | EFO_0007885 | |
| Disease | aspartate aminotransferase measurement | 3.04e-03 | 904 | 116 | 10 | EFO_0004736 | |
| Disease | Retinitis pigmentosa | 3.13e-03 | 74 | 116 | 3 | cv:C0035334 | |
| Disease | IGF-1 measurement | 3.22e-03 | 488 | 116 | 7 | EFO_0004627 | |
| Disease | endometriosis | 3.25e-03 | 252 | 116 | 5 | EFO_0001065 | |
| Disease | Paroxysmal atrial fibrillation | 3.40e-03 | 156 | 116 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 3.40e-03 | 156 | 116 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.40e-03 | 156 | 116 | 4 | C2585653 | |
| Disease | Atrial Fibrillation | 3.72e-03 | 160 | 116 | 4 | C0004238 | |
| Disease | lean body mass | 3.92e-03 | 379 | 116 | 6 | EFO_0004995 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKHKFMVQTIFAPPN | 91 | Q9P0L0 | |
| HPKVMLKAIPSFLNS | 1381 | Q14146 | |
| FAISAKPLTRHMPQN | 1536 | O00555 | |
| KPLTRHMPQNKQSFQ | 1541 | O00555 | |
| ADTKKANHMFIPPSA | 521 | F5H4B4 | |
| NNPLSKKLSPVHSEM | 171 | Q9NR48 | |
| HRASKANKKPMQLPR | 111 | Q9BWU1 | |
| PIQEKSPKQALSSHM | 656 | O43683 | |
| KNLPGHSKNTPLAMS | 1506 | Q68DQ2 | |
| FPRAFKKLLHTMNVP | 166 | Q9NUP1 | |
| AMLPSSQRPKGNHTK | 741 | Q86UK0 | |
| KSRKFMRPNAFHSPL | 806 | Q8IYW2 | |
| AASPTNPMKFLRNKA | 76 | Q8NEA5 | |
| KNTSRTHKIIAPANM | 116 | Q8IZP0 | |
| APKTTMGRSNPLFHQ | 691 | P78325 | |
| KPESKTSIHNFMATP | 1131 | Q16720 | |
| NSVTSPHSKEKRMPF | 251 | Q08289 | |
| NHPSRKKVNFLDMSL | 16 | Q9P127 | |
| PAFISKTNNHIMKLT | 256 | P05546 | |
| HFIMSPPTKSKLKRQ | 6 | Q96JH8 | |
| KMNLENRPPRSSKAH | 81 | Q7L8S5 | |
| SHEQNSLFLMKPKPG | 551 | Q92585 | |
| PPVQQANSLHTSKMK | 41 | Q9NUD7 | |
| LPQNPKSSEHTLAKM | 711 | Q9Y4B6 | |
| RALFLMTKSNFQPPK | 221 | Q8IVH8 | |
| AMPTLSFSHLKRPQQ | 161 | Q96G91 | |
| PKSQRKRPNLFASDM | 146 | Q13823 | |
| PSAFKPVVPKNFHSM | 161 | O60299 | |
| RKRSLATMDSPPHQK | 1811 | Q14676 | |
| QPKTMQIEKSFDAHP | 1071 | Q9UPT6 | |
| LPHFTKQPESMNVTR | 196 | Q12866 | |
| MPFSNSHNALKLRFP | 1 | P12277 | |
| RKAFQNPSTVTLMKP | 711 | Q8NI77 | |
| LRALAMKFKTTHAPP | 751 | Q12809 | |
| KSQQVFASPSKHPMD | 136 | Q6ICG6 | |
| LQKAGPKPSSLSMAH | 3476 | Q9UPA5 | |
| PHKTLYVPNRKVNSM | 116 | Q8NA75 | |
| LHTPKKMSQGPTLFS | 26 | Q14153 | |
| MPVHAQKKPSLTESS | 1196 | Q6ZU69 | |
| EAKSPLQSQPHSRMK | 351 | Q9UI08 | |
| NIKTPAFHPQRMISR | 571 | A8MRT5 | |
| QRLSPNTMVTPHKKS | 61 | Q15040 | |
| FRKQTPSAGKAMHTP | 1771 | P46013 | |
| TGFMKHTPTKLRAPA | 36 | Q96PU9 | |
| AHREPKSQKPFRKMQ | 351 | Q2M2Z5 | |
| KKHRTSLPSPMFSRN | 531 | Q9BXW6 | |
| NPKPATVFSHKNMEL | 96 | Q92643 | |
| QMFKRNPSHRPSATT | 236 | P51956 | |
| EHFSKFSPSPLSMKQ | 21 | Q15119 | |
| KRPPNVKSSNNSMLL | 3116 | O60494 | |
| PKNSSFNPAALSRHM | 386 | P23771 | |
| PTMNFVHTSPKVKNL | 41 | Q9NZH6 | |
| KKNKLMSLLTSPHQP | 326 | Q96RU3 | |
| PLSHRFNEFMTSKPK | 366 | Q96RU3 | |
| TFKGRSPMLNHLKKN | 86 | A8TX70 | |
| PHVKKTGMFSIRLPN | 226 | B0YJ81 | |
| HRMSSTPVKAVPQKT | 611 | Q9HC77 | |
| TPCTIKITHKNQAPM | 766 | Q9Y6T7 | |
| SPKDTFPPNHMSNTK | 3871 | Q12955 | |
| VKNMPTKPNGTLSHK | 376 | P20794 | |
| MPKNKKRNTPHRGSS | 1 | O00458 | |
| NSKIAQAFPSKMHSP | 1406 | O15021 | |
| VSNLMAPAPSTVHFK | 106 | Q13118 | |
| SSAARHKMTLNPRKQ | 401 | Q9ULL0 | |
| KTRRKNTSAHFLPMV | 191 | O15520 | |
| VQPKMSASFVPDHKA | 2486 | P21817 | |
| VSSPHQRASAKMKPI | 321 | Q8NE79 | |
| KRTSEATKMHAPPIN | 256 | P48444 | |
| SQILTPPQLSSRMKH | 61 | Q5TDP6 | |
| APTKSLVSHIPKQMS | 1581 | Q5THK1 | |
| SLPMTHSLQLSKNKR | 186 | Q16557 | |
| PSGIKTNIKSASMHP | 251 | Q96G25 | |
| KQMPNFTHIQTSPSK | 151 | O14829 | |
| PALSQKMSPFKRQLS | 281 | P49757 | |
| RPASRSNLKEKMNAP | 106 | Q9Y6R4 | |
| KMSGSPVQKPTLHRS | 391 | Q6ZRF8 | |
| MSFSVHNQKGSKRPL | 1 | Q8TBZ9 | |
| LPHTSARTQLPQSMK | 366 | Q8TEL6 | |
| KMTYPKTQLQHSLPL | 196 | Q9HC36 | |
| PQPKSSHSLNMDKVA | 276 | P0C617 | |
| NTSKKMSTLAHPPNI | 26 | Q9BXB7 | |
| TPSQVKMSPSYHQSK | 1331 | Q8N3P4 | |
| KRKMQAQSPYLPHSG | 226 | Q8WUT9 | |
| KPASKQDRHMLDSPQ | 56 | Q8IX21 | |
| NMPSKSVHSLKPSDI | 56 | Q6P1J6 | |
| VKSLPMRAQFKANHP | 356 | Q96P15 | |
| QTKLRLSHRPAFMPS | 356 | Q08043 | |
| LPQFTTRSELMKKHQ | 101 | Q96HQ2 | |
| LPHFKMNSAAPSNKD | 151 | B2RD01 | |
| MNKPAFQAIRSHSPA | 1541 | Q8N3C0 | |
| KTAFQISMAKPRPNS | 871 | O75339 | |
| SSMNDVQPVKKPHFK | 271 | Q8NA57 | |
| NNKMPLSTHRFKREP | 106 | Q9H5F2 | |
| KMSRIFNPHLNKTAN | 76 | Q14135 | |
| GKRSHSMKRNPNAPV | 46 | Q9Y2H5 | |
| SRLNRQSSPAMPHKV | 541 | Q9UKE5 | |
| QSSPAMPHKVANRIS | 546 | Q9UKE5 | |
| TNVKNMAKLSPIPHT | 11 | Q6ZT77 | |
| IHNMSVKAMRFPPKS | 486 | O43242 | |
| SAATMKPHPTVQKQS | 591 | Q8NFH8 | |
| SCKNQRPMFPPIHKS | 1096 | Q5TZJ5 | |
| PKSSPHEVKFQMQRK | 591 | Q9UQR0 | |
| LTSMQDHSRPPQGKK | 711 | Q8TEQ6 | |
| AKMPNASFSTLKIQP | 86 | P01733 | |
| GNFMDPSKRHQRKVP | 261 | P13686 | |
| RMKILKPASAHSPTQ | 291 | Q86V25 | |
| DFHLSTREMPQSKPK | 496 | Q9BWV7 | |
| GLRKKAFVHMPTLPN | 81 | Q2KHR2 | |
| TQMPDPKTFKQHFES | 46 | Q9Y5V0 | |
| AKMPNASFSTLKIQP | 86 | A0A0B4J2E0 | |
| SRKKPVLSPHNSIMF | 26 | Q8N9G6 | |
| MSFPRGSQTQKIKHP | 1 | Q6P2C0 | |
| KRKSPGQPMRTHTLT | 1526 | Q7Z7G8 | |
| SQPHTKPSVFVMKNG | 1 | B7Z8K6 | |
| MKPKSPHNSGLVNLT | 346 | Q96JM2 | |
| VSKTPVQKFTPSHMF | 241 | A2RU30 | |
| VQHFPLARPKSLMQK | 231 | Q96DT7 | |
| PAKHLIASMLSKNPE | 306 | Q9NYY3 | |
| SAPHVTMFSPKTNIK | 461 | A2RRH5 | |
| NHLTPKKVEMQRSLP | 2381 | Q9BXT5 | |
| KDSSPPMLLHQVNKT | 41 | Q9BR11 | |
| TNSQPFKLDPKMTHK | 531 | Q9UJV3 | |
| IPVSSFNHMPKLRTF | 196 | O75093 | |
| LMTICQKHFPTDPSK | 321 | Q99633 | |
| NHQRAPPKTFEKSMM | 631 | P11387 | |
| FSHADAQKMKRLPTP | 396 | Q14966 | |
| EKIPNKMSAFRNHCP | 26 | Q8TEY7 | |
| GKSFPSKSQLQMHKR | 476 | P51508 | |
| MFQPKNSKSLLLRAH | 336 | P22033 | |
| ARKRLSPDQMKHSPN | 96 | Q86TC9 | |
| KFPVHMRSKTSLNPN | 531 | Q96PU5 |